Cargando…

Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells

Triple negative breast cancer (TNBC) is observed in ~15% of breast cancers and results in poor survival and increased distant metastases. Within the tumor are present a small portion of cancer stem cells that drive tumorigenesis and metastasis. In this study, we aimed to elucidate whether the two na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramamoorthy, Prabhu, Dandawate, Prasad, Jensen, Roy A., Anant, Shrikant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146582/ https://www.ncbi.nlm.nih.gov/pubmed/33924995 http://dx.doi.org/10.3390/biomedicines9050482

Ejemplares similares

Suppressing STAT5 signaling affects osteosarcoma growth and stemness
por: Subramaniam, Dharmalingam, et al.
Publicado: (2020)

The therapeutic potential of triptolide and celastrol in neurological diseases
por: Cui, Yueran, et al.
Publicado: (2022)

Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis
por: Subramaniam, Dharmalingam, et al.
Publicado: (2021)

Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells
por: Ponnurangam, Sivapriya, et al.
Publicado: (2015)

Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway
por: Dandawate, Prasad, et al.
Publicado: (2020)

Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies
por: Standing, David, et al.
Publicado: (2023)

Natural products triptolide, celastrol, and withaferin A inhibit the chaperone activity of peroxiredoxin I
por: Zhao, Qian, et al.
Publicado: (2015)

Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling
por: Subramaniam, Dharmalingam, et al.
Publicado: (2012)

Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine
por: Jiang, Qi-Wei, et al.
Publicado: (2015)

A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
por: Chen, Shao-Ru, et al.
Publicado: (2018)

CYP450s-Activity Relations of Celastrol to Interact with Triptolide Reveal the Reasons of Hepatotoxicity of Tripterygium wilfordii
por: Jin, Chunhuan, et al.
Publicado: (2019)

Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications
por: Wagh, Pushkaraj Rajendra, et al.
Publicado: (2021)

Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex
por: Weir, Scott J., et al.
Publicado: (2021)

Methanolic Extracts of Bitter Melon Inhibit Colon Cancer Stem Cells by Affecting Energy Homeostasis and Autophagy
por: Kwatra, Deep, et al.
Publicado: (2013)

Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone
por: Krishnamachary, Balaji, et al.
Publicado: (2019)

Celastrol attenuates the inflammatory response by inhibiting IL-1β expression in triple-negative breast cancer cells
por: You, Daeun, et al.
Publicado: (2021)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression
por: Roy, Badal Chandra, et al.
Publicado: (2019)

Cancer Stem Cell Metabolism and Potential Therapeutic Targets
por: Snyder, Vusala, et al.
Publicado: (2018)

Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer
por: Escher, Taylor E., et al.
Publicado: (2021)

3508 Ciclopirox Olamine Demonstrates Inhibitory Effects on Esophageal Tumor Cells
por: Ryan, Randi, et al.
Publicado: (2019)

Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
por: Varghese, Elizabeth, et al.
Publicado: (2018)

Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
por: Angulo, Pablo, et al.
Publicado: (2017)

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
por: Shi, Peiguo, et al.
Publicado: (2017)

Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB)
por: Yan, Fei, et al.
Publicado: (2020)

Celastrol improves self-renewal and differentiation of human tendon-derived stem cells by suppressing Smad7 through hypoxia
por: Wu, Tianyi, et al.
Publicado: (2017)

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
por: Lee, Kha-Liang, et al.
Publicado: (2019)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy
por: Kasi, Anup, et al.
Publicado: (2021)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
por: Dai, Meiou, et al.
Publicado: (2016)

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
por: Liu, Cuiping, et al.
Publicado: (2020)

Celastrol inhibits store operated calcium entry and suppresses psoriasis
por: Yuan, Xiaoman, et al.
Publicado: (2023)

NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer
por: Zhou, Lei, et al.
Publicado: (2020)

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
por: Giuli, M. V., et al.
Publicado: (2019)

Therapeutic Potential of Triptolide in Treating Bone-Related Disorders
por: Gang, Wu, et al.
Publicado: (2022)

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

ALDH Maintains the Stemness of Lung Adenoma Stem Cells by Suppressing the Notch/CDK2/CCNE Pathway
por: Li, Zhongjun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lr2p4ch1jl8he4tqtiquboaj8o